Template:ST elevation myocardial infarction: Difference between revisions

Jump to navigation Jump to search
Raviteja Reddy Guddeti (talk | contribs)
No edit summary
Tarek Nafee (talk | contribs)
No edit summary
 
(19 intermediate revisions by 6 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Acute coronary syndrome|Acute Coronary Syndrome Main Page]]
|-
!
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''ST elevation myocardial infarction Microchapters
'''ST Elevation Myocardial Infarction Microchapters'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
Line 79: Line 84:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[ST elevation myocardial infarction risk stratification|Risk Stratification]]
[[ST elevation myocardial infarction triggers|Triggers]]
|-  
|-  
!
!
Line 85: Line 90:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[ST elevation myocardial infarction triggers|Triggers]]
[[ST elevation myocardial infarction natural history and complications|Natural History and Complications]]
|-
!
 
|- bgcolor="Pink"
!
[[ST elevation myocardial infarction risk stratification and prognosis|Risk Stratification and Prognosis]]
|-  
|-  
!
!
Line 91: Line 102:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[ST elevation myocardial infarction natural history|Natural History, Complications and Prognosis]]
[[ST elevation myocardial infarction in pregnancy|Pregnancy]]
|-  
|-  
!
!
Line 176: Line 187:
!
!
[[ST elevation myocardial infarction initial care|Initial Care]]
[[ST elevation myocardial infarction initial care|Initial Care]]
:[[ST elevation myocardial infarction oxygen therapy|Oxygen]]
:[[ST elevation myocardial infarction nitrate therapy|Nitrates]]
:[[ST elevation myocardial infarction analgesic therapy|Analgesics]]
:[[ST elevation myocardial infarction aspirin therapy|Aspirin]]
:[[ST elevation myocardial infarction beta blocker therapy|Beta Blockers]]
:[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy|Antithrombins]]
:[[Coronary care unit|The coronary care unit]]
:[[Step down unit|The step down unit]]
:[[STEMI and Out-of-Hospital Cardiac Arrest|STEMI and Out-of-Hospital Cardiac Arrest]]
:Pharmacologic Reperfusion
::[[ST elevation myocardial infarction reperfusion therapy|Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI)]]
::[[ST elevation myocardial infarction fibrinolytic therapy|Fibrinolysis]]
:::[[ST elevation myocardial infarction fibrinolysis| Reperfusion at a Non–PCI-Capable Hospital:Recommendations]]
:Mechanical Reperfusion
::[[Door-to-balloon|The importance of reducing Door-to-Balloon times]]
::[[ST elevation myocardial infarction primary percutaneous coronary intervention|Primary PCI]]
::[[ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration|Adjunctive and Rescue PCI]]
::[[ST elevation myocardial infarction rescue percutaneous coronary intervention|Rescue PCI]]
::[[ST elevation myocardial infarction facilitated percutaneous coronary intervention|Facilitated PCI]]
::[[ST elevation myocardial infarction adjunctive percutaneous coronary intervention|Adjunctive PCI]]
::[[ST elevation myocardial infarction coronary artery bypass grafting|CABG]]
::[[ST elevation myocardial infarction management of patients who were not reperfused|Management of Patients Who Were Not Reperfused]]
::[[ST elevation myocardial infarction assessing success of reperfusion|Assessing Success of Reperfusion]]
:Antithrombin Therapy
::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy|Antithrombin therapy]]
::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Unfractionated Heparin|Unfractionated heparin]]
::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Enoxaparin|Low Molecular Weight Heparinoid Therapy]]
::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Bivalirudin|Direct Thrombin Inhibitor Therapy]]
::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Fondaparinux|Factor Xa Inhibition]]
::[[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|DVT prophylaxis]]
::[[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|Long term anticoagulation]]
:Antiplatelet Agents
::[[ST elevation myocardial infarction aspirin therapy|Aspirin]]
::[[ST elevation myocardial infarction thienopyridine therapy|Thienopyridine Therapy]]
::[[ST elevation myocardial infarction glycoprotein IIbIIIa inhibition|Glycoprotein IIbIIIa Inhibition]]
:Other Initial Therapy
::[[ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge|Inhibition of the Renin-Angiotensin-Aldosterone System]]
::[[ST elevation myocardial infarction magnesium therapy|Magnesium Therapy]]
::[[ST elevation myocardial infarction glucose control|Glucose Control]]
::[[ST elevation myocardial infarction calcium channel blocker therapy|Calcium Channel Blocker Therapy]]
::[[ST elevation myocardial infarction lipid management|Lipid Management]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ST elevation myocardial infarction discharge care|Pre-Discharge Care]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT|Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT]]
|-  
|-  
!
!
Line 181: Line 243:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[ST elevation myocardial infarction discharge care|Pre-Discharge Care]]
[[ST elevation myocardial infarction Post Hospitalization|Post Hospitalization Plan of Care]]
|-  
|-  
!
!
Line 188: Line 250:
!
!
[[ST elevation myocardial infarction secondary prevention|Long-Term Medical Therapy and Secondary Prevention]]
[[ST elevation myocardial infarction secondary prevention|Long-Term Medical Therapy and Secondary Prevention]]
|-  
:[[ST elevation myocardial infarction secondary prevention|Overview]]
!
:[[ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge|Inhibition of the Renin-Angiotensin-Aldosterone System]]
:[[ST elevation myocardial infarction cardiac rehabilitation|Cardiac Rehabilitation]]
:[[ST elevation myocardial infarction pacemaker implantation|Pacemaker Implantation]]
:[[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|Long Term Anticoagulation]]
:[[ST elevation myocardial infarction implantable cardioverter defibrillator|Implantable Cardioverter Defibrillator]]
:[[ICD implantation within 40 days of myocardial infarction]]
:[[ICD within 90 days of revascularization]]
|-


!
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!

Latest revision as of 00:11, 4 March 2017

Acute Coronary Syndrome Main Page

ST Elevation Myocardial Infarction Microchapters

Home

Patient Information

Overview

Pathophysiology

Pathophysiology of Vessel Occlusion
Pathophysiology of Reperfusion
Gross Pathology
Histopathology

Causes

Differentiating ST elevation myocardial infarction from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History and Complications

Risk Stratification and Prognosis

Pregnancy

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Cardiac MRI

Echocardiography

Coronary Angiography

Treatment

Pre-Hospital Care

Initial Care

Oxygen
Nitrates
Analgesics
Aspirin
Beta Blockers
Antithrombins
The coronary care unit
The step down unit
STEMI and Out-of-Hospital Cardiac Arrest
Pharmacologic Reperfusion
Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI)
Fibrinolysis
Reperfusion at a Non–PCI-Capable Hospital:Recommendations
Mechanical Reperfusion
The importance of reducing Door-to-Balloon times
Primary PCI
Adjunctive and Rescue PCI
Rescue PCI
Facilitated PCI
Adjunctive PCI
CABG
Management of Patients Who Were Not Reperfused
Assessing Success of Reperfusion
Antithrombin Therapy
Antithrombin therapy
Unfractionated heparin
Low Molecular Weight Heparinoid Therapy
Direct Thrombin Inhibitor Therapy
Factor Xa Inhibition
DVT prophylaxis
Long term anticoagulation
Antiplatelet Agents
Aspirin
Thienopyridine Therapy
Glycoprotein IIbIIIa Inhibition
Other Initial Therapy
Inhibition of the Renin-Angiotensin-Aldosterone System
Magnesium Therapy
Glucose Control
Calcium Channel Blocker Therapy
Lipid Management

Pre-Discharge Care

Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT

Post Hospitalization Plan of Care

Long-Term Medical Therapy and Secondary Prevention

Overview
Inhibition of the Renin-Angiotensin-Aldosterone System
Cardiac Rehabilitation
Pacemaker Implantation
Long Term Anticoagulation
Implantable Cardioverter Defibrillator
ICD implantation within 40 days of myocardial infarction
ICD within 90 days of revascularization

Case Studies

Case #1

Case #2

Case #3

Case #4

Case #5

ST elevation myocardial infarction On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on ST elevation myocardial infarction

CDC on ST elevation myocardial infarction

ST elevation myocardial infarction in the news

Blogs on ST elevation myocardial infarction

Directions to Hospitals Treating ST elevation myocardial infarction

Risk calculators and risk factors for ST elevation myocardial infarction